ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Grants IND Approval for Phase II Clinical Trial Using Stemedica's itMSC Therapy for COVID-19 Patients
September 30, 2020Stemedica Cell Technologies, Inc. has received U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) approval for "A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety ... -
Biohaven to Proceed with Intranasal Vazegepant Trial for COVID-19 Lung Inflammation
April 14, 2020Biohaven Pharmaceutical announced it submitted Pre-IND/IND material to the U.S. Food and Drug Administration (FDA) to initiate a Phase 2 study of vazegepant. -
Windtree to Pursue Clinical Study of Lung Injury Treatment in COVID-19 Patients
March 25, 2020Windtree Therapeutics announced it is planning to study its proprietary KL4 surfactant to potentially mitigate the pulmonary effects of severe COVID-19 infection.
Pharma Sources Insight January 2025
